{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:04:32Z","timestamp":1792292672537,"version":"4.4.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Chirurgie Plastique Esth\u00e9tique"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.anplas.2017.11.007","type":"journal-article","created":{"date-parts":[[2017,12,28]],"date-time":"2017-12-28T19:33:11Z","timestamp":1514489591000},"page":"175-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Complex upper arm reconstruction using an antero-lateral thigh free flap after an extravasation of Yttrium-90-ibritumomab Tiuxetan: A case report and literature review"],"prefix":"10.1016","volume":"63","author":[{"given":"A.","family":"Baus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Keilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.-S.","family":"Bich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Entine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Brachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Duhamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-C.","family":"Amabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.V.","family":"Malfuson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.anplas.2017.11.007_bib0140","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1093\/annonc\/mdh214","article-title":"Extravasation of systemic hemato-oncological therapies","volume":"15","author":"Ener","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.anplas.2017.11.007_bib0145","doi-asserted-by":"crossref","DOI":"10.1046\/j.1468-3083.2002.00564.x","article-title":"Skin necrosis from extravasation of vinorelbine","author":"Moreno de Vega","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.anplas.2017.11.007_bib0150","doi-asserted-by":"crossref","DOI":"10.1053\/jpon.2000.8063","article-title":"Evaluation and treatment of chemotherapy extravasation injuries","author":"Kassner","year":"2000","journal-title":"J Pediatr Oncol Nurs"},{"issue":"6","key":"10.1016\/j.anplas.2017.11.007_bib0155","first-page":"1741","article-title":"Outcome of chemotherapy extravasation in a large patient series using a standardised management","volume":"23","author":"Pluschnig","year":"2015","journal-title":"Protocol"},{"key":"10.1016\/j.anplas.2017.11.007_bib0160","series-title":"X-ray treatment: its origin, birth and early history","author":"Grubb\u00e9","year":"1949"},{"issue":"4","key":"10.1016\/j.anplas.2017.11.007_bib0165","first-page":"435","article-title":"A review of non-cancer effects especially circulatory and ocular diseases, Little Radiation Epidemiology Branch, National Cancer Institute, 9609 Medical Center Drive MSC, Bethesda, USA","volume":"52","author":"Mark","year":"2013","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.anplas.2017.11.007_bib0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00411-009-0250-z","article-title":"Review and meta-analysis of epidemiological associations between low\/moderate doses of ionizing radiation and circulatory disease risks, and heir possible mechanisms","volume":"49","author":"Little","year":"2010","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.anplas.2017.11.007_bib0175","article-title":"ICRP Statement on tissue reactions and early and late effects of radiation in normal tissues and organs \u2013 threshold doses for tissue reactions in a radiation protection context","volume":"41","author":"ICRP","year":"2012","journal-title":"Ann ICRP"},{"key":"10.1016\/j.anplas.2017.11.007_bib0180","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/jrr\/rru019","article-title":"Classification of radiation effects for dose limitation purposes: history, current situation and future prospects","volume":"55","author":"Hamada","year":"2014","journal-title":"J Radiation Res"},{"key":"10.1016\/j.anplas.2017.11.007_bib0185","article-title":"Extravasation of Yttrium-90 Ibritumomab Tiuxetan: a case study","volume":"2","author":"Siebeneck","year":"2007","journal-title":"Clin J Oncol Nursing"},{"key":"10.1016\/j.anplas.2017.11.007_bib0190","article-title":"Extravasation of therapeutic Yttrium-90-Ibritumomab Tiuxetan: a case report","author":"Gethin Williams","year":"2006","journal-title":"Can Biotherap Radiopharmaceut"},{"key":"10.1016\/j.anplas.2017.11.007_bib0195","article-title":"Radiation dosimetry results and safety correlations from 90-Y- Ibritumomab Tuixetan radioimmunotherapy for relapsed or refractory non-Hodgkin's lymphoma: combined data from four clinical trials","author":"Wiseman","year":"2003","journal-title":"J Nucl Med"},{"key":"10.1016\/j.anplas.2017.11.007_bib0200","series-title":"Medical management of radiation accidents","author":"Gusev","year":"2001"},{"key":"10.1016\/j.anplas.2017.11.007_bib0205","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-109-9-730","article-title":"Radiation accidents and nuclear energy: medical consequences and therapy","author":"Champlin","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.anplas.2017.11.007_bib0210","doi-asserted-by":"crossref","DOI":"10.1093\/rpd\/ncs160","article-title":"Stem cell therapy: from bench to bedside","author":"Tamarat","year":"2012","journal-title":"Radiat Prot Dosimetry"},{"issue":"5","key":"10.1016\/j.anplas.2017.11.007_bib0215","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1586\/14737140.2.5.485","article-title":"Zevalin: the first radioimmunotherapy approved for the treatment of lymphoma","volume":"2","author":"Grillo-Lopez","year":"2002","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.anplas.2017.11.007_bib0220","article-title":"Administering continuous vesicant chemotherapy in the ambulatory setting","author":"Chrystal","year":"1997","journal-title":"Intraven Nurs"},{"key":"10.1016\/j.anplas.2017.11.007_bib0225","article-title":"Radioimmunotherapy in non-Hodgkin's lymphoma: focus on 90-Yttrium-Ibritumomab Tiuxetan","author":"White","year":"2004","journal-title":"J Exp Ther Oncol"},{"key":"10.1016\/j.anplas.2017.11.007_bib0230","doi-asserted-by":"crossref","DOI":"10.1053\/j.semnuclmed.2003.11.002","article-title":"Safety and efficaccy of radioimmunotherapy with 90-Yttrium-Ibritumomab Tiuxetan","author":"Borghaei","year":"2004","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.anplas.2017.11.007_bib0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.soncn.2010.11.010","article-title":"Extravasation management: clinical update","author":"Schulmeister","year":"2011","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.anplas.2017.11.007_bib0240","doi-asserted-by":"crossref","DOI":"10.1093\/jjco\/hyt186","article-title":"Incidence, risk factors and treatment outcomes of extravasation of cytotoxic agents in an outpatient chemotherapy clinic","author":"Sakaida","year":"2014","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.anplas.2017.11.007_bib0245","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1524-475X.2009.00562.x","article-title":"Emerging therapy for improving wound repair of severe radiation burns using local bone marrow-derived stem cell administrations","volume":"18","author":"Bey","year":"2010","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.anplas.2017.11.007_bib0250","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/HP.0b013e3181c9f79a","article-title":"New emerging concepts in the medical management of local radiation injury","volume":"98","author":"Benderitter","year":"2010","journal-title":"Health Phys"},{"key":"10.1016\/j.anplas.2017.11.007_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-006-0166-5","article-title":"Human mesenchymal stem cells favour healing of the cutaneous radiation syndrome in a xenogenic transplant model","volume":"86","author":"Fran\u00e7ois","year":"2007","journal-title":"Ann Hematol"},{"key":"10.1016\/j.anplas.2017.11.007_bib0260","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2217\/17460751.2.5.785","article-title":"New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy","volume":"2","author":"Lataillade","year":"2007","journal-title":"Regen Med"},{"key":"10.1016\/j.anplas.2017.11.007_bib0265","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0190-9622(00)90218-4","article-title":"The radiation accident in Georgia: clinical appearance and diagnosis of cutaneous radiation syndrome","volume":"42","author":"Gottl\u00f6ber","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.anplas.2017.11.007_bib0270","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/milmed\/167.suppl_1.110","article-title":"Management of cutaneous radiation injuries: diagnostic and therapeutic principles of the cutaneous radiation syndrome","volume":"167","author":"Peter","year":"2002","journal-title":"Mil Med"}],"container-title":["Annales de Chirurgie Plastique Esth\u00e9tique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0294126017301954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0294126017301954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:34:00Z","timestamp":1759530840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0294126017301954"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0294126017301954"],"URL":"https:\/\/doi.org\/10.1016\/j.anplas.2017.11.007","relation":{},"ISSN":["0294-1260"],"issn-type":[{"value":"0294-1260","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complex upper arm reconstruction using an antero-lateral thigh free flap after an extravasation of Yttrium-90-ibritumomab Tiuxetan: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"Annales de Chirurgie Plastique Esth\u00e9tique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anplas.2017.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}